Tirzepatide — lab test, April 2026
COA 2604020017 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
RedD2604020017Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 11.08 mg
111% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.8 mg using the measured mass, against 2.5 mg on the label — 11% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2604020017 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 12 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tesamorelin, performed by freedomdiagnosticstesting.com on April 3, 2026. Reported purity: 99.129%. Net content: 11.08 mg against 10 mg labeled (111% of label). Tested content exceeds the labeled amount by 11%. Endotoxins: Pass (Replicate 1 & Replicate 2). Batch TS102602. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion